StoxGud Sign in
40

Galaxy Medicare Limited

NSE: GML · Unclassified

₹17.70-1.67%03 Nov 2026

Ask the data

Instant answers about Galaxy Medicare Limited — computed from its filings, no language model
Market cap₹27 cr
Current price₹17.70
High / Low₹51 / ₹15
P/E7.9
P/B0.67
Book value₹26.5
ROE8.5%
ROCE11.2%
Debt / equity0.10
Dividend yield5.27%
EPS (TTM)₹2.25
Face value₹10

Price & valuation

split & bonus adjusted · pick a metric and range

Annual performance

annual · ₹ crore · line = operating margin
FY26
Revenue40.0
EBITDA4.2
Operating margin10.6%
Interest0.3
Depreciation0.6
Profit before tax4.7
Tax1.3
Net profit3.4
EPS ₹2.25
Operating cash flow1.8
Capex1.6
Dividend paid1.4
Total assets48.8
Equity40.3

Half-yearly performance

last 2 half years · ₹ crore
H1 FY26H2 FY26
Revenue18.721.3
Operating profit2.91.4
Operating margin15.3%6.4%
Other income0.31.0
Interest0.10.2
Depreciation0.30.2
Profit before tax2.81.9
Tax0.80.5
Net profit2.01.4
EPS ₹1.700.92

Returns & margins

trailing-twelve-month, per half year
H2 FY26
ROE8.5%
ROCE11.2%
Net margin8.5%
EBITDA margin10.6%
Debt / equity0.10
Interest coverage18.44
Asset turnover0.82

Balance sheet

equity vs borrowings over time · ₹ crore
SEP '25MAR '26
Share capital15.215.2
Other equity / reserves24.325.2
Total equity39.540.3
Borrowings2.54.2
Current liabilities5.27.3
Non-current liabilities0.71.1
Total assets45.448.8
Property, plant & equipment14.015.0
Investments3.02.9
Inventories6.05.6
Receivables6.27.6
Cash & equivalents11.813.2

Cash flow

annual · ₹ crore · line = free cash flow
FY26
Cash from operations1.8
Cash from investing-13.9
Cash from financing12.1
Capex1.6
Free cash flow0.2
Dividends paid1.4

Where the assets sit

Mar '26 · ₹ crore
Fixed assets (PPE)
₹15.0 cr31%
Investments
₹2.9 cr6%
Inventories
₹5.6 cr12%
Receivables
₹7.6 cr16%
Cash & equivalents
₹13.2 cr27%
Other assets
₹4.4 cr9%

Peer comparison

largest in Unclassified · this company in bold
CompanyMarket cap ₹crPriceP/EP/BROE
Avantel Limited36,86,04,549138.69—1059360.680.0%
Ducol Organics And Colours Limited19,55,275120.00—20089.130.0%
Jio Platforms Limited12,57,1811,406.40—3.57—
SBI Funds Management Limited1,01,750499.55———
Tamilnadu Telecommunication Limited91,3149.93———
Manipal Health Enterprises Limited76,294646.70———
INDO-MIM Limited59,0421,219.50———
AvenuesAI Limited45,138129.25153.69.516.2%
Dhoot Transmission Limited32,7611,601.60—8.11—
3M India Limited31,07127,570.0053.817.5732.7%
Galaxy Medicare Limited2717.707.90.678.5%

StoxGud checklist: Neutral setup · 4/10

  • Price above 50-day average
  • Price above 200-day average
  • 50-day average above 200-day (uptrend)
  • RSI in healthy 40–70 zone
  • Positive 1-year return
  • Return on equity above 15%
  • Debt to equity below 1
  • Revenue growing year on year
  • Net profit margin above 10%
  • P/E below industry median

A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.

Returns & technicals

1 month-2.5%
6 months+10.6%
1 year—
3Y CAGR—
5Y CAGR—
10Y CAGR—
50-day avg₹17.68
200-day avg₹18.76
RSI (14)57

FAQs

What is the share price of Galaxy Medicare Limited?

Galaxy Medicare Limited (GML) closed at ₹17.70 on NSE on 03 Nov 2026.

What is the market cap of Galaxy Medicare Limited?

₹27 crore at the latest close.

What is the P/E ratio of Galaxy Medicare Limited?

7.9, on trailing-twelve-month earnings from its filings.

How fast is Galaxy Medicare Limited growing?

Not enough filed history yet to measure Galaxy Medicare Limited's growth.

How profitable is Galaxy Medicare Limited?

On a trailing-twelve-month basis return on equity is 8.5%, return on capital employed 11.2%, operating margin 10.6%, net margin 8.5%.

How much debt does Galaxy Medicare Limited have?

Galaxy Medicare Limited is lightly geared: debt to equity is 0.10 with borrowings of ₹4 cr against cash of ₹13 cr (balance sheet of 2026-03-31). Operating profit covers interest 18.4 times.

Financials parsed from Galaxy Medicare Limited's own XBRL filings to NSE (standalone), ₹ crore unless marked. Half-yearly from H1 FY26, annual from FY26, balance sheet from Sep '25. * = derived (full year minus the other half). This company is on NSE's SME platform and reports results half-yearly. Information only, not investment advice.